Fig. 2From: Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonistsAlteration of CXCR4 protein expression in PaCa cells by GEM. PaCa cells were treated with different concentrations of GEM (0–20 μM) for 72 h. The concentrations of CXCR4 protein in a MIA PaCa-2 GEM-S, b MIA PaCa-2 GEM-R, c AsPC-1 GEM-S d and AsPC-1 GEM-R were measured by ELISA. Values are expressed as means ± SDs. Multiple comparisons were performed by using one-way ANOVA followed by Dunnett’s test. **, P < 0.01; *, P < 0.05 versus control (0 μM)Back to article page